Group One Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-22,000
| Closed | -$4K | – | 5862 |
|
|
2018
Q1 | $4K | Sell |
22,000
-200,700
| -90% | -$185K | ﹤0.01% | 4579 |
|
|
2017
Q4 | $287K | Buy |
222,700
+6,800
| +3% | +$11.1K | ﹤0.01% | 2678 |
|
|
2017
Q3 | $458K | Sell |
215,900
-11,400
| -5% | -$27.8K | ﹤0.01% | 2154 |
|
|
2017
Q2 | $659K | Sell |
227,300
-111,500
| -33% | -$334K | 0.01% | 1758 |
|
|
2017
Q1 | $1.17M | Buy |
338,800
+305,900
| +930% | +$1.21M | 0.01% | 1233 |
|
|
2016
Q4 | $57K | Sell |
32,900
-30,000
| -48% | -$70.5K | ﹤0.01% | 3200 |
|
|
2016
Q3 | $209K | Buy |
62,900
+60,150
| +2,187% | +$227K | ﹤0.01% | 2445 |
|
|
2016
Q2 | $12K | Sell |
2,750
-23,760
| -90% | -$107K | ﹤0.01% | 4033 |
|
|
2016
Q1 | $149K | Sell |
26,510
-8,650
| -25% | -$112K | ﹤0.01% | 2531 |
|
|
2015
Q4 | $605K | Buy |
35,160
+10,200
| +41% | +$243K | 0.01% | 1661 |
|
|
2015
Q3 | $527K | Sell |
24,960
-27,450
| -52% | -$941K | 0.01% | 1740 |
|
|
2015
Q2 | $2.59M | Sell |
52,410
-14,050
| -21% | -$840K | 0.04% | 598 |
|
|
2015
Q1 | $5.2M | Buy |
66,460
+34,960
| +111% | +$2.17M | 0.08% | 246 |
|
|
2014
Q4 | $1.91M | Sell |
31,500
-4,070
| -11% | -$204K | 0.03% | 666 |
|
|
2014
Q3 | $1.51M | Sell |
35,570
-2,760
| -7% | -$148K | 0.02% | 855 |
|
|
2014
Q2 | $2.37M | Buy |
38,330
+5,200
| +16% | +$302K | 0.04% | 601 |
|
|
2014
Q1 | $2.15M | Sell |
33,130
-10,970
| -25% | -$742K | 0.04% | 583 |
|
|
2013
Q4 | $2.48M | Buy |
44,100
+12,760
| +41% | +$717K | 0.04% | 532 |
|
|
2013
Q3 | $1.92M | Buy |
31,340
+17,110
| +120% | +$1.16M | 0.04% | 583 |
|
|
2013
Q2 | $832K | Buy |
+14,230
| New | +$875K | 0.02% | 947 |
|
Other funds holding OREX
Group One Trading's OREX Position: Q2 2018 in Review
Group One Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 38,499 shares — an estimated $8K sold.
Group One Trading first reported a position in OREX in Q2 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Group One Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Group One Trading sold 38,499 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $8K.
- Group One Trading first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 13 quarters.
- Group One Trading's Orexigen Therapeutics, Inc. position peaked at $1.78M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.